Encapsia is more than just a data management tool-it is a comprehensive ecosystem designed to streamline every facet of clinical trial operations. Built from the ground up with the needs of modern research in mind, Encapsia integrates data capture, management, and analysis into a single, intuitive platform. Its suite of innovative applications-including web-based Electronic Data Capture (EDC), direct data capture (eSource), and a Home Visit app-enables flexible, real-time data collection from virtually any location. Whether it’s at a clinical site, in a patient’s home, or via wearables and third-party labs, Encapsia ensures that no data point is missed and no opportunity for insight is lost. At the heart of Encapsia’s value proposition is its unified database architecture. Unlike traditional systems that silo data across multiple platforms, Encapsia brings all trial information together in one place. This means that every stakeholder-from sponsors and CROs to site staff and regulatory bodies-has immediate access to live, actionable data visualizations and analytics. The result is a dramatic acceleration in decision-making, a significant reduction in errors, and a marked improvement in overall data quality. With Encapsia, the days of waiting for batch updates or struggling with incompatible systems are over. Encapsia’s commitment to regulatory compliance is unwavering. The platform is designed to meet the stringent requirements of global regulatory authorities, ensuring that every trial conducted on Encapsia is audit-ready at all times. Moreover, its open architecture allows for easy integration with other essential clinical systems, such as electronic Patient Reported Outcomes (ePRO), electronic Clinical Outcome Assessments (eCOA), and Interactive Response Technology (IRT). This interoperability makes Encapsia an ideal choice for sponsors and CROs looking to adopt decentralized or hybrid trial models, where flexibility and connectivity are paramount. One of the most compelling aspects of Encapsia is its user-centric design. Recognizing that clinical trials are only as strong as the people who run them, Encapsia is accessible on a wide range of devices-smartphones, tablets, and desktops-making it easy for site staff and patients to participate from anywhere. This not only reduces the burden on participants but also opens up new possibilities for patient-centric trial designs. By enabling remote data collection and minimizing disruptions to daily life, Encapsia helps ensure that trials are more inclusive, efficient, and representative of real-world populations. For sponsors, Encapsia offers a clear competitive advantage. By providing a single source of truth for all trial data, the platform eliminates the need for costly and time-consuming reconciliations. Its advanced analytics capabilities allow sponsors to monitor trial progress in real time, identify potential issues before they escalate, and make data-driven adjustments on the fly. This level of agility is simply not possible with legacy systems, giving Encapsia users a significant edge in today’s fast-paced research environment. For CROs, Encapsia is a game-changer. Its intuitive interface and comprehensive feature set reduce the learning curve for new users, while its robust security and compliance features ensure that sensitive data is always protected. By streamlining workflows and automating routine tasks, Encapsia enables CROs to deliver higher quality results in less time, ultimately driving down costs and increasing client satisfaction. For patients, Encapsia represents a new era of convenience and engagement. The platform’s mobile-friendly design and remote data capture capabilities mean that patients can participate in trials from the comfort of their own homes. This not only improves retention rates but also makes clinical research more accessible to diverse populations, including those who may have previously been excluded due to geographic or logistical barriers.Encapsia is not just another clinical trial platform-it is a transformative solution that empowers every stakeholder in the research process. By unifying data, accelerating insights, and enabling flexible, patient-centric trial designs, Encapsia is setting a new standard for excellence in clinical research. For sponsors, CROs, and patients alike, Encapsia is the key to faster, smarter, and more successful trials.
Encapsia sets itself apart from other clinical trial management solutions through its unified, cloud-based platform that integrates all aspects of data capture, management, and analysis into one intuitive environment. Unlike many traditional systems that rely on separate, disconnected modules for different functions, Encapsia brings together data from eSource, web-based EDC, home visits, wearable devices, and third-party laboratories within a single, harmonized database. This approach eliminates data silos, ensures consistency, and provides immediate, actionable insights for all stakeholders. A standout feature is Encapsia’s Home Visit app, which allows clinical data to be collected directly from patients’ homes or any community setting-even when internet access is unavailable. The app operates on standard tablets or mobile devices and automatically synchronizes data with the cloud once a connection is restored. This flexibility not only reduces the burden on patients but also broadens trial access to include those who may be unable to travel to clinical sites, making studies more inclusive and representative. Encapsia’s user-centric design is evident in its intuitive interface, which is accessible across smartphones, tablets, and desktop computers. This accessibility makes it easy for site staff, monitors, and patients to interact with the system, regardless of their location or technical expertise. Real-time data synchronization and advanced analytics empower research teams to monitor trial progress, identify issues early, and make informed decisions quickly. The platform also includes robust features to ensure data integrity and regulatory compliance. Automated validation checks, comprehensive audit trails, and built-in compliance with standards such as HIPAA and 21 CFR Part 11 provide transparency and confidence throughout the trial process. Additionally, Encapsia is designed for seamless integration with other clinical trial technologies, including ePRO, eCOA, IRT, and legacy systems. This interoperability supports the adoption of decentralized or hybrid trial models with minimal disruption, enabling organizations to manage complex, multi-site studies efficiently and adapt to evolving research needs. In summary, Encapsia stands out for its unified, flexible approach to clinical data management, robust support for decentralized trials, real-time analytics, and user-friendly design-making it a future-ready solution for the evolving needs of modern clinical research.
Seller
Encapsia
HQ Location
Horsham, United Kingdom
Company Website
https://www.encapsia.com
Contact
+44 8000608766
Year Founded
2020
Third-Party Integrations
Real-Time Data
Multiple Data Sources
Forms Management
Document Imaging
Data Verification
CRF Tracking
API
Not Available.
Not Available.
Not Available.
Not Available.
Yes, the Encapsia platform incorporates artificial intelligence (AI) as part of its core capabilities. Encapsia uses AI and machine learning to enhance the management, analysis, and interpretation of clinical trial data. Specifically, the platform leverages AI-driven algorithms for real-time analytics, enabling immediate interpretation of various digital health measurements, such as those collected from wearable sensors and medical images. This allows sponsors and research teams to identify issues quickly, make faster decisions, and optimize trial performance within the system itself.
Not Available.
Not Available.
Not Available.
